StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$6.08−0.16 (-2.56%)

Close on Nov 13, 2026Market cap $41.23MP/E –Yield –

Instil Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Instil Bio's operating cash flow for the twelve months ending Sep 30, 2026 was -$15.46M. For fiscal 2025 it was -$36.62M. The highest annual figure on record is -$29.62M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.62M–
FY2024Dec 31, 2024-$55.70M–
FY2023Dec 31, 2023-$82.03M–
FY2022Dec 31, 2022-$180.16M–
FY2021Dec 31, 2021-$122.14M–
FY2020Dec 31, 2020-$29.62M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$2.41M–
Q2 FY2026Jun 30, 2026-$4.64M–
Q1 FY2026Mar 31, 2026-$1.34M–
Q4 FY2025Dec 31, 2025-$7.08M–
Q3 FY2025Sep 30, 2025-$10.56M–
Q2 FY2025Jun 30, 2025-$14.79M–
Q1 FY2025Mar 31, 2025-$4.20M–
Q4 FY2024Dec 31, 2024-$10.56M–
Q3 FY2024Sep 30, 2024-$20.13M–
Q2 FY2024Jun 30, 2024-$10.61M–
Q1 FY2024Mar 31, 2024-$14.39M–
Q4 FY2023Dec 31, 2023-$13.38M–
Q3 FY2023Sep 30, 2023-$14.43M–
Q2 FY2023Jun 30, 2023-$19.56M–
Q1 FY2023Mar 31, 2023-$34.66M–
Q4 FY2022Dec 31, 2022-$36.98M–
Q3 FY2022Sep 30, 2022-$40.88M–
Q2 FY2022Jun 30, 2022-$47.26M–
Q1 FY2022Mar 31, 2022-$55.05M–
Q4 FY2021Dec 31, 2021-$42.79M–
Q3 FY2021Sep 30, 2021-$29.40M–
Q2 FY2021Jun 30, 2021-$32.22M–
Q1 FY2021Mar 31, 2021-$17.73M–
Q4 FY2020Dec 31, 2020-$16.82M–
Q3 FY2020Sep 30, 2020-$7.24M–
Q2 FY2020Jun 30, 2020-$3.28M–
Q1 FY2020Mar 31, 2020-$2.28M–

More Instil Bio figures

See a number that looks wrong?